Cargando…

Immunogenic cell death in cancer: concept and therapeutic implications

Mammalian cells responding to specific perturbations of homeostasis can undergo a regulated variant of cell death that elicits adaptive immune responses. As immunogenic cell death (ICD) can only occur in a precise cellular and organismal context, it should be conceptually differentiated from instanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galluzzi, Lorenzo, Kepp, Oliver, Hett, Erik, Kroemer, Guido, Marincola, Francesco M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979428/ https://www.ncbi.nlm.nih.gov/pubmed/36864446 http://dx.doi.org/10.1186/s12967-023-04017-6

Ejemplares similares

Immunogenic cell death in radiation therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Detection of immunogenic cell death and its relevance for cancer therapy
por: Fucikova, Jitka, et al.
Publicado: (2020)

Mitochondrial regulation of cell death: a phylogenetically conserved control
por: Galluzzi, Lorenzo, et al.
Publicado: (2016)

Combinatorial Strategies for the Induction of Immunogenic Cell Death
por: Bezu, Lucillia, et al.
Publicado: (2015)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”
por: Bezu, Lucillia, et al.
Publicado: (2015)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Immunogenicity of cell death driven by immune effectors
por: Galluzzi, Lorenzo, et al.
Publicado: (2020)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

An unexpected link between immunogenic cell death and inhibition of gene transcription
por: Humeau, Juliette, et al.
Publicado: (2020)

Functions of BCL-X(L) at the Interface between Cell Death and Metabolism
por: Michels, Judith, et al.
Publicado: (2013)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012)

Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
por: Gomes-da-Silva, Lígia C., et al.
Publicado: (2020)

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
por: Sukkurwala, Abdul Qader, et al.
Publicado: (2014)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2013)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021)

Trial Watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2014)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Hormesis, cell death and aging
por: Martins, Isabelle, et al.
Publicado: (2011)

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
por: Michaud, Mickaël, et al.
Publicado: (2014)

A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)

Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus
por: Gomes-da-Silva, Lígia Catarina, et al.
Publicado: (2018)

Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors
por: Kroemer, Guido, et al.
Publicado: (2016)

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2020)

Trial watch: Cardiac glycosides and cancer therapy
por: Menger, Laurie, et al.
Publicado: (2013)

Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells
por: Zhang, Jing, et al.
Publicado: (2023)

Tumor-intrinsic determinants of immunogenic cell death modalities
por: Workenhe, Samuel T, et al.
Publicado: (2021)

Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
por: Kroemer, Guido, et al.
Publicado: (2021)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

AKT as a therapeutic target for autophagy induction and cancer therapy
por: Wu, Qi, et al.
Publicado: (2021)

Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
por: Petrazzuolo, Adriana, et al.
Publicado: (2021)

Cell Death Signaling and Anticancer Therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2011)

Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol
por: Morselli, Eugenia, et al.
Publicado: (2009)

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
por: Galluzzi, Lorenzo, et al.
Publicado: (2020)

Trial watch: Peptide-based vaccines in anticancer therapy
por: Bezu, Lucillia, et al.
Publicado: (2018)

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8o3rc2gl9i0hp1qje5273akd5j